New Developments in Biologic Therapy for Psoriasis
What
is a podcast?
A podcast is an audio recording posted online — much like a radio show
for your computer. It can be downloaded and listened to on your computer, iPod
or any other device that plays MP3's. It can also be streamed via the web — so
you can listen to it anywhere, at any time.
To learn more about podcasting and how to enjoy this exciting new
feature of eMedical Dermatology Review, click
here.
To
listen to the Podcast, follow the links below.
Right-click
to download the Edition here.
This saves the podcast directly on your computer's hard drive. There
you can manage and play it like any song or audio file by using your music
software (iTunes, Windows Media, Real Player, etc...) You can also transfer
it to your iPod or MP3 player to listen to it on-the-go.
You
can listen on the web here.
If you want to listen to the eMedical Dermatology Review Podcast right
away, just click on the above link and it will open an internet browser and
play the podcast for you via streaming media on the web.
Please note: This podcast is a large file, so please be patient as the
file downloads via the web. Once it's finished downloading,
it will take a few more minutes for the
toolbar to show. This could take a few minutes.
You
can subscribe to the eMedical Dermatology Review
Podcast here.
When you subscribe, you'll get new editions of the eMedical Dermatology
Review Podcast automatically downloaded to your hard drive as soon as it
becomes available. And just like the downloaded editions, you can manage
and play it like any song or audio file by using your music software (iTunes,
Windows Media, etc...) You can also transfer it to your iPod or MP3 player,
Real Player, etc. to listen to it on-the-go.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing, and the University of Tennessee College of Pharmacy. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Physicians
The Johns Hopkins University School of Medicine
designates this educational activity
for a maximum of 0.5 AMA PRA
Category 1 Credit(s)TM. Physicians should only claim
credit commensurate with the extent of their participation in the activity.
Nurses
This 0.5 contact hour Educational Activity
(Provider Directed/Learner Paced)
is provided by The Institute for Johns Hopkins Nursing. Each podcast
carries a maximum of 0.5 contact hours or a total of 7.0 contact hours
for the six newsletters in this program.
Pharmacists This
program is approved for 0.5 hour
credit (0.05 CEUs) for the podcast and is co-sponsored by the University
of Tennessee College of Pharmacy who is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy education.
A statement of CE credit will be mailed within 4 weeks of successful
completion and evaluation of the program. ACPE Program #064-999-07-251-H01.
Grievance Policy: A participant, sponsor, faculty
member or other individual wanting to file a grievance with respect
to any aspect of a program sponsored or co-sponsored by the UTCOP
may contact the Associate Dean for Continuing Education in writing.
The grievance will be reviewed and a response will be returned within
45 days of receiving the written statement. If not satisfied, an
appeal to the Dean of the College of Pharmacy can be made for a second
level of review.
This
activity has been developed for
the Dermatologist, PharmD, Nurses,
Dermasurgeon, Dermatopathologist, Pediatric Dermatologist, Immunodermatologist,
Wound Care Specialist.
The
Johns Hopkins University School of Medicine and The Institute for
Johns Hopkins Nursing take responsibility for the content, quality,
and the scientific integrity of this CE activity.
At the conclusion of
this activity, participants should be able to:
Identify which biologic agents are considered safe to use in patients with chronic infectious disease conditions such as Hepatitis C and tuberculosis
Discuss the appropriate use of biologics in patients with multiple sclerosis, lupus and/or malignancies
Discuss the appropriate use of biologics in patients with congestive heart failure
It
is the policy of The Johns Hopkins University School of Medicine that
the faculty and provider disclose real or apparent conflict of interest
relating to the topics of this educational activity, and also disclose
discussions of unlabeled/unapproved uses of drugs or devices during
their presentation(s). Detailed disclosure will be made in each newsletter.
Bernard
A. Cohen, MD has indicated a past and current financial
relationship with Novartis, Pharmaceuticals, Astellas Pharma Inc.,
Medicis and Connetics. He served on the Speaker's Bureau for Novartis,
Pharmaceuticals, Astellas Pharma Inc., and Medicis. He has also
received grants for studies from Novartis, Pharmaceuticals and Astellas
Pharma Inc. and received support for a fellowship program from Connetics.
Susan
Matra Rabizadeh, MD, MBA has disclosed no relationships
with commercial supporters.
Mark
Lebwohl, MD has disclosed that he has received grants for
clinical research
and educational
activities from,
has served as an advisor, consultant and speaker to, and has served
as an investigator for Abbott, Amgen, Astellas, Centecor, Genentech
and Novartis.
Elizabeth
Sloand, PhD,
CRNP, has
disclosed no relationships
with commercial supporters.
Dr.Lebwohl has indicated that there will be references to unlabeled/unapproved uses of drugs or products in this presentation. Etanercept for hepatitis C is off-label; etanercept, adalimumab and infliximab are off-label for lupus